Lessons learned from the preclinical drug discovery of asoprisnil and ulipristal for non-surgical treatment of uterine leiomyomas

Author： Maruo Takeshi   Ohara Noriyuki   Yoshida Shigeki   Nakabayashi Koji   Sasaki Hiroko   Xu Qin   Matsuo Hiroya   Sitruk-Ware Regine   Yamada Hideto  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.6, Iss.9, 2011-09, pp. : 897-911

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lasofoxifene, from the preclinical drug discovery to the treatment of postmenopausal osteoporosis

By Gennari Luigi   Merlotti Daniela   Stolakis Konstantinos   Nuti Ranuccio  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 2, 2011-02 ,pp. : 205-217

Informa Healthcare

Access to resources Recommend Favorite

Medicinal Compound Celastrol As a Potential Clinical Anticancer Drug: Lessons Learned From Preclinical Studies

By  

Clinical Cancer Drugs, Vol. 3, Iss. 1, 2016-05 ,pp. : 63-73

Bentham Science Publishers

Access to resources Recommend Favorite

Medicinal Compound Celastrol As a Potential Clinical Anticancer Drug: Lessons Learned From Preclinical Studies

By  

Clinical Cancer Drugs, Vol. 3, Iss. 1, 2016-03 ,pp. : 63-73

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in the non-surgical treatment of melanoma

By Hersey Peter  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 1, 2002-01 ,pp. : 75-85

Informa Healthcare

Access to resources Recommend Favorite

Pharmacophore Discovery - Lessons Learned

By  

Current Pharmaceutical Design, Vol. 9, Iss. 20, 2003-08 ,pp. : 1649-1664

Bentham Science Publishers

Access to resources Recommend Favorite